Company: UPC
Filing Date: 2025-03-20
Form Type: 6-K
Source: 0001213900-25-025300
Chunk: 0

Company: Universe Pharmaceuticals INC
Filing Date: 2025-03-20
Form: 6-K
Chunk 0
---
<div align='center'>UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of March 2025

Commission file number: 001-40231

Universe Pharmaceuticals INC

265 Jingjiu Avenue

Jinggangshan Economic and Technological Development Zone

Ji’an, Jiangxi, China 343100

+86-0796-8403309

(Address of principal executive offices)</div>

Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F.

<div align='center'>Form 20-F ☒
Form 40-F ☐

Exhibits</div>

| Exhibit No. |     | Description                                                                |
| 99.1        |     | Press Release – Universe Pharmaceuticals INC Announces Share Consolidation |

<div align='center'>1

SIGNATURES</div>

Pursuant to the requirements
of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto
duly authorized.

| Date: March 20, 2025 | Universe Pharmaceuticals INC 
 By:                          | /s/ Gang Lai            |
|:---------------------|:-----------------------------|:------------------------|
|                      |                              | Gang Lai                |
|                      |                              | Chief Executive Officer |

<div align='center'>2</div>